Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy

By Leitao M.M.   Hummer A.   Dizon D.S.   Aghajanian C.   Hensley M.   Sabbatini P.   Venkatraman E.   Spriggs D.R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Clinical Applicability of the ATP Cell Viability Assay as a Predictor of Chemoresponse in Platinum-Resistant Epithelial Ovarian Cancer Using Nonsurgical Tumor Cell Samples

By Ng T.Y.   Ngan H.Y.S.   Cheng D.K.L.   Wong L.C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 405-408

Elsevier

Access to resources Recommend Favorite

Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K.   Daikeler T.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

Phase II Study of Vinorelbine in the Treatment of Platinum-Resistant Ovarian Carcinoma

By Sorensen P.   Hoyer M.   Jakobsen A.   Malmstrom H.   Havsteen H.   Bertelsen K.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 58-62

Elsevier

Access to resources Recommend Favorite

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

By Westermann A.M.   Grosen E.A.   Katschinski D.M.   Jager D.   Rietbroek R.   Schink J.C.   Tiggelaar C.L.   Jager E.   Zum Vorde sive Vording P.   Neuman A.   Knuth A.   Van Dijk J.D.P.   Wiedemann G.J.   Robins H.I.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite